Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Furst

Showing results (101-110 of 755) with videos related to

Pageof 76
Sort By:
Clinical Pharmacology and Therapeutics|May 1, 1975
Lack of effect of rheumatoid arthritis on clonixin metabolismD E Furst, H E Paulus
Clinical and Experimental Rheumatology|November 7, 2001
Future directions in pain managementD E Furst, D C Manning
Scandinavian Journal of Rheumatology|October 2, 2001
D-penicillamine is not an effective treatment in systemic sclerosisD E Furst, P J Clements
Annals of the Rheumatic Diseases|April 18, 2002
Guidelines for the treatment of osteoarthritisD E Furst, J R Caldwell
The American Journal of Occupational Therapy : Official Publication of the American Occupational Therapy Association|February 1, 1987
Effects of splinting in the treatment of hand contractures in progressive systemic sclerosisM W Seeger, D E Furst
Annals of Translational Medicine|March 26, 2019
Timely renal transplantation for scleroderma end-stage kidney disease patients can improve outcomes and quality of lifeThasia G Woodworth, Daniel E Furst
Clinical and Experimental Rheumatology|July 1, 1985
Pulmonary disease in systemic lupus erythematosusR D Brasington, D E Furst
The Journal of Rheumatology|December 5, 2002
Pharmacogenetics for the individualization of treatment of rheumatic disorders using azathioprineErnest G Seidman, Daniel E Furst
Current Opinion in Rheumatology|April 23, 2003
Immunoglobulin for rheumatic diseases in the twenty-first century: take it or leave it?Yolanda Braun-Moscovici, Daniel E Furst
Rheumatic Diseases Clinics of North America|March 21, 2007
Disease-modifying antirheumatic drug use in the elderly rheumatoid arthritis patientVeena K Ranganath, Daniel E Furst
Pageof 76

Showing results (101-110 of 755) with videos related to

Sort By:
Pageof 76
Clinical Pharmacology and Therapeutics|May 1, 1975
Lack of effect of rheumatoid arthritis on clonixin metabolismD E Furst, H E Paulus
Clinical and Experimental Rheumatology|November 7, 2001
Future directions in pain managementD E Furst, D C Manning
Scandinavian Journal of Rheumatology|October 2, 2001
D-penicillamine is not an effective treatment in systemic sclerosisD E Furst, P J Clements
Annals of the Rheumatic Diseases|April 18, 2002
Guidelines for the treatment of osteoarthritisD E Furst, J R Caldwell
The American Journal of Occupational Therapy : Official Publication of the American Occupational Therapy Association|February 1, 1987
Effects of splinting in the treatment of hand contractures in progressive systemic sclerosisM W Seeger, D E Furst
Annals of Translational Medicine|March 26, 2019
Timely renal transplantation for scleroderma end-stage kidney disease patients can improve outcomes and quality of lifeThasia G Woodworth, Daniel E Furst
Clinical and Experimental Rheumatology|July 1, 1985
Pulmonary disease in systemic lupus erythematosusR D Brasington, D E Furst
The Journal of Rheumatology|December 5, 2002
Pharmacogenetics for the individualization of treatment of rheumatic disorders using azathioprineErnest G Seidman, Daniel E Furst
Current Opinion in Rheumatology|April 23, 2003
Immunoglobulin for rheumatic diseases in the twenty-first century: take it or leave it?Yolanda Braun-Moscovici, Daniel E Furst
Rheumatic Diseases Clinics of North America|March 21, 2007
Disease-modifying antirheumatic drug use in the elderly rheumatoid arthritis patientVeena K Ranganath, Daniel E Furst
Pageof 76